Drug intelligence / Profile preview

Euflavine

Development stage: Unknown
Modality: Small Molecules
Administration: Topical

Overview

Euflavine is a topical antiseptic and disinfectant primarily used for the treatment of infected wounds, burns, blisters, insect bites, and for general skin disinfection[1][3][4][5]. It belongs to the acridine class of compounds and acts by intercalating into nucleic acids, thereby inhibiting bacterial and viral replication[7]. Euflavine is typically formulated as a 1% topical solution. Its main use is dermatological as an anti-infective agent.

Brand names: ACRIVINEBURNOL
Other names: 3,6-diamino-10-methylacridinium chloride

Targets

dsRNA (Double-stranded RNA)

Beyond the preview

Go deeper on Euflavine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Euflavine.

Explore the full profile